Alliance/NCTN/NCORP/AFT at 2023 ASCO     

May 25, 2023

The 59th Annual Meeting of the American Society of Clinical Oncology (ASCO) will convene June 2-6, bringing together thousands of oncology professionals from around the world in person. This year's meeting theme is "Partnering with Patients: The Cornerstone of Cancer Care and Research." Studies spanning the spectrum of cancer prevention and care, from immunotherapy and precision medicine to

New Trial Alert: Alliance A012103 Triple Negative Breast Cancer

May 10, 2023

Alliance A012103: OptimICE-pCR: De-escalation of therapy in early-stage TNBC patients who achieve pCR after neoadjuvant chemotherapy with checkpoint inhibitor therapy

Overview: Sara Tolaney, MD, Dana-Farber Cancer Institute, leads this phase III trial that compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a patholo

Dr. Evanthia Galanis Elected Alliance Group Chair-Elect

May 5, 2023

The Alliance Board of Directors has elected Evanthia Galanis, MD, as Group Chair-Elect of the Alliance for Clinical Trials in Oncology at the 2023 Alliance Spring Virtual Group Meeting on May 5. Dr. Galanis will take office in November 2023 and will serve a six-year term.

“I’m honored to be elected to serve as Group Chair of the Alliance,” Dr. Galanis said. “I am excited to lead an organiza

Older News